We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
- Authors
Gerstein, H C; Yusuf, S; Bosch, J; Pogue, J; Sheridan, P; Dinccag, N; Hanefeld, M; Hoogwerf, B; Laakso, M; Mohan, V; Shaw, J; Zinman, B; Holman, R R; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators
- Abstract
Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drug's ability to prevent type 2 diabetes in individuals at high risk of developing the condition.
- Publication
Lancet (London, England), 2006, Vol 368, Issue 9541, p1096
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(06)69420-8